急性肺损伤时循环ACE阳性内皮微粒增加
研究通过流式细胞术检测人肺微血管内皮细胞培养上清、小鼠肺损伤模型及82例脓毒症患者血中ACE阳性内皮微粒(EMP),发现炎症刺激后ACE+ EMP增加,小鼠循环ACE+ EMP及ACE+ EMP/EMP比值升高且与湿干肺比相关,脓毒症患者入院时ACE+ EMP及比值在发展为ARDS者中显著升高。
要点
- 脓毒症患者入院时循环ACE+ EMP及ACE+ EMP/EMP比值升高与后续ARDS发生相关。
- 小鼠肺损伤模型中循环ACE+ EMP及比值高于对照,比值与肺湿干比相关。
- ACE+ EMP可能作为脓毒症患者发展为ARDS的预后标志物。
核心结论
- 循环ACE+ EMP可能是脓毒症患者发展为ARDS的预后标志物。
研究设计与样本
- 研究检测人微血管内皮细胞培养上清、小鼠肺损伤模型及脓毒症患者(n=82)血中EMP和ACE+ EMP,采用流式细胞术。
主要发现
- 人肺微血管内皮细胞暴露于炎症刺激后培养上清中ACE+ EMP增加。
- 小鼠肺损伤模型中循环ACE+ EMP及ACE+ EMP/EMP比值高于对照(p<0.001)。
- 小鼠ACE+ EMP/EMP比值与湿/干肺比值相关(rs=0.775,p<0.001)。
- 脓毒症患者入院时循环ACE+ EMP及ACE+ EMP/EMP比值在发展为ARDS者中较未发展者显著升高(p<0.001)。
临床怎么用
- 在脓毒症患者中可关注入院时循环ACE+ EMP及ACE+ EMP/EMP比值,辅助评估ARDS发生风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Circulating endothelial microparticles (EMPs) are considered to be markers of endothelial injury, and lung microvascular endothelial cells express higher levels of angiotensin-converting enzyme (ACE). The aim of this study is to examine whether the number of ACE+ microvascular EMPs could be a prognostic marker for the development of acute respiratory distress syndrome (ARDS) in septic patients.The numbers of EMPs and ACE+ EMPs in the culture supernatant from human microvascular endothelial cells, as well as in the blood of mouse lung injury models and septic patients (n=82), were examined using flow cytometry.ACE+ EMPs in the culture supernatant from pulmonary microvascular endothelial cells increased after exposure to an inflammatory stimulus. In the mouse lung injury models, the circulating ACE+ EMPs and ACE+ EMP/EMP ratio were higher than in the controls (p<0.001). The ACE+ EMP/EMP ratio was correlated with the wet/dry lung ratio (rs=0.775, p<0.001). The circulating ACE+ EMPs and ACE+ EMP/EMP ratio on admission were significantly increased in septic patients who developed ARDS compared with septic patients who did not (p<0.001).Therefore, circulating ACE+ EMPs may be a prognostic marker for the development of ARDS in the septic patients.
引用
- Takei Y, Yamada M, Saito K, et al. Increase in circulating ACE-positive endothelial microparticles during acute lung injury. Eur Respir J. 2019. PMID: 31320458. doi:10.1183/13993003.01188-2018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。